Camlin Fine Sciences Limited

NSE:CAMLINFINE.NS

110.3 (INR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 16,130.6216,815.6414,089.25211,806.17910,402.0838,833.1427,146.8945,339.3054,893.4225,582.7455,086.7083,736.2343,352.4881,676.0471,402.8181,041.118794.096470.312
Cost of Revenue 11,709.7498,132.3157,688.5295,945.2165,409.7654,786.2564,260.7983,093.1842,031.0072,704.9642,757.3531,646.422,831.7491,459.8951,199.671844.588649.475453.667
Gross Profit 4,420.8718,683.3256,400.7235,860.9634,992.3184,046.8862,886.0962,246.1212,862.4152,877.7812,329.3552,089.814520.739216.152203.147196.53144.62116.645
Gross Profit Ratio 0.2740.5160.4540.4960.480.4580.4040.4210.5850.5150.4580.5590.1550.1290.1450.1890.1820.035
Reseach & Development Expenses 77.40666.73453.87650.81543.9966.56618.81525.55921.00824.78927.23717.239000000
General & Administrative Expenses 3,986.253417.991423.02304.213316.928214.202170.888204.351117.259454.783059.34000000
Selling & Marketing Expenses 86.86175.194154.221148.891212.056211.002208.29189.154110.25361.4740149.969000000
SG&A 4,073.113593.185577.241453.104528.984425.204379.178393.505227.512516.257343.734671.055000000
Other Expenses -54.91557.99353.43831.2953.76870.88216.91316.6081,834.9322,123.2291,724.4451,662.834166.991.745101.896100.42555.98217.693
Operating Expenses 4,128.0287,255.7165,340.2594,282.773,968.2363,597.762,949.2481,989.5562,083.4522,148.0181,751.6821,680.073247.1399.187101.896100.42555.98217.693
Operating Income 292.8431,531.087970.7661,525.244979.024406.721-63.152256.565500.184528.335348.638235.071273.609116.965101.25196.10588.639-1.048
Operating Income Ratio 0.0180.0910.0690.1290.0940.046-0.0090.0480.1020.0950.0690.0630.0820.070.0720.0920.112-0.002
Total Other Income Expenses Net -1,285.278-727.317-30.981-474.281-397.016-239.793-244.111-299.414-278.779-201.428-229.035-174.672-165.445-25.351-67.777-57.553-49.859-22.172
Income Before Tax -992.435803.77939.7851,050.963582.008166.928-307.263-42.849500.184528.335348.638235.069108.16491.61433.47438.55238.78-23.22
Income Before Tax Ratio -0.0620.0480.0670.0890.0560.019-0.043-0.0080.1020.0950.0690.0630.0320.0550.0240.0370.049-0.049
Income Tax Expense 56.316405.666336.066397.383283.7136.87-67.54132.524141.984-22.07961.26183.83569.40717.56522.67317.12113.922-4.984
Net Income -927.534521.064606.778509.634303.1865.772-296.431-142.553358.237550.273287.13150.95637.92971.08412.10824.46126.091-18.236
Net Income Ratio -0.0580.0310.0430.0430.0290.001-0.041-0.0270.0730.0990.0560.040.0110.0420.0090.0230.033-0.039
EPS -5.583.114.654.132.50.048-2.7-1.43.735.773.061.610.410.750.490.270.36-0.33
EPS Diluted -5.53.074.563.682.50.048-2.64-1.43.715.753.041.60.410.740.490.270.36-0.33
EBITDA 1,078.9042,110.7231,797.9661,887.6241,165.664678.292192.449424.044911.491865.801695.533546.191408.741173.424147.95139.527126.97219.796
EBITDA Ratio 0.0670.1260.1280.160.1120.0770.0270.0790.1860.1550.1370.1460.1220.1030.1050.1340.160.042